Optic Nerve Neoplasms: Clinical Trials

3 trials for Optic Nerve Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 withdrawn. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Terminated 1, Withdrawn 1

Follow Optic Nerve Neoplasms: new trials by email Literature Review of Optic Nerve Neoplasms trials Research Report on Optic Nerve Neoplasms

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
Temozolomide, ANP Therapy - Optic Nerve Glioma
Phase 3WithdrawnBurzynski Research Institute2011-12-012017-07-26
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
cyproheptadine hydrochloride, placebo - Cancer
Phase 3TerminatedUniversity of South Florida222010-06-012015-07-02
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
carboplatin, lomustine, procarbazine hydrochloride - Brain Tumors, Central Nervous System Tumors
Phase 3CompletedChildren's Oncology Group4281997-04-012013-09-09

Narrower conditions

Optic Nerve Glioma (3)  ·  Astrocytoma (2)  ·  Body Weight Changes (1)  ·  Bone Neoplasms (1)  ·  Brain Neoplasms (1)  ·  Cachexia (1)  ·  Central Nervous System Neoplasms (1)  ·  Chondrosarcoma (1)  ·  Choroid Plexus Neoplasms (1)  ·  Familial ependymoma (1)  ·  Fibrosarcoma (1)  ·  Glioblastoma (1)  ·  Hemangiosarcoma (1)  ·  Hepatoblastoma (1)  ·  Liposarcoma (1)

Broader conditions

Cranial Nerve Diseases (3)  ·  Cranial Nerve Neoplasms (3)  ·  Eye Diseases (3)  ·  Glioma (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Nervous System Diseases (3)  ·  Nervous System Neoplasms (3)  ·  Neuroectodermal Tumors (3)  ·  Optic Nerve Diseases (3)  ·  Peripheral Nervous System Neoplasms (3)

Interventions

Carboplatin (1)  ·  Cyproheptadine (1)  ·  Lomustine (1)  ·  Procarbazine (1)  ·  Temozolomide (1)  ·  Thioguanine (1)  ·  Vincristine (1)  ·  antineoplaston A10 (1)  ·  antineoplaston AS 2-1 (1)

Sponsors

Burzynski Research Institute (1)  ·  Children's Oncology Group (1)  ·  University of South Florida (1)

Countries

United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Switzerland (1)

Top investigators

Jeffrey P. Krischer, PhD (1)  ·  Joann Ater, MD (1)  ·  Stanislaw R Burzynski, MD, PhD (1)

Results publications

PMID 22665535

NIH funding

U10CA081920 (1)